Congratulations to the team from NHS Tayside’s Blood Sciences and Gastroenterology department, who alongside Primary Care colleagues, won the Global Distinction UNIVANTS of Healthcare award for introducing a test to investigate patients visiting their GP with new bowel symptoms. Consultant Clinical Scientist Judith Strachan said: “FIT testing in Tayside has revolutionised the investigation of local
The #1 Resource for Faecal Immunochemical Testing (FIT) in the UK and Eire
- digestivedx@alphalabs.co.uk
- +44 (0) 23 8048 3000
Faecal Immunochemical Testing News
The Scottish Bowel Screening Programme formally restarts on the 12th October following a brief suspension due to the effects of the Coronavirus pandemic. Bowel Cancer is highly treatable if caught early, and bowel screening is an incredibly effective, and quick, way to help find bowel cancer early. Read Bowel Cancer UK’s update here
Correspondence to the BJS Society from Mr. Nigel D’Souza and Mr. Muti Abulafi regarding the use of FIT in the colorectal cancer two-week-wait (2WW) pathway, during the COVID-19 pandemic. With limitations on endoscopy resources during the pandemic, the authors outline the importance of appropriate triaging to alleviate the burden on endoscopy resource, whilst achieving maximum
A blog from Katy Parker, a PHE Screening helpdesk advisor, about the importance of the Bowel Screening test after her father, who sadly passed away after a short battle with Bowel Cancer, admitted to having never done the test. Read the full blog post from Public Health Screening
Uptake of bowel screening in Scotland has increased from 56.2% to 64.1%, for comparable 18-month periods before and after the introduction of FIT. Prior to this new screening test, national uptake had never previously reached the standard of 60%. The Faecal Immunochemical Test (FIT), was launched on 20th November 2017, replacing the Faecal Occult Blood Test
Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages, according to new calculations released by Cancer Research UK today. Read the full article from Cancer Research UK
